Abstract
We present a patient with dermal argyria as a cutaneous manifestation of a silver-coated megaprosthesis used for a distal femoral osteosarcoma. Histological and electron microscopic analyses also showed silver deposition in the dermis.
Similar content being viewed by others
References
Hillmann A, Hoffmann C, Gosheger G, Krakau H, Winkelmann W. Malignant tumor of the distal part of the femur or the proximal part of the tibia: Endoprosthetic replacement or rotationplasty. Functional outcome and quality-of-life measurements. Malignant tumor of the distal part of the femur or the proximal part of the tibia: Endoprosthetic replacement or rotationplasty 1999;81:462–8.
Grimer RJ, Belthur M, Chandrasekar C, Carter SR, Tillman RM. Two-stage revision for infected endoprostheses used in tumor surgery. Clin Orthop Relat Res 2002;395:193–203.
Hussmann B, Johann I, Kauther MD, Landgraeber S, Jäger M, Lendemans S. Measurement of the silver ion concentration in wound fluids after implantation of silver-coated megaprostheses: Correlation with the clinical outcome. Biomed Res Int 2013;2013:763096.
Bechert T, Steinrücke P, Guggenbichler JP. A new method for screening antiinfective biomaterials. Nat Med 2000;6:1053–6.
Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. Pathogenesis of foreign body infection 1984;73:1191–200.
Tobin EJ, Bambauer R. Silver coating of dialysis catheters to reduce bacterial colonization and infection. Ther Apher Dial 2003;7:504–9.
Hardes J, Ahrens H, Gebert C, Streitbuerger A, Buerger H, Erren M, et al. Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials 2007;28:2869–75.
Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M, et al. Silver-coated megaendoprostheses in a rabbit model: An analysis of the infection rate and toxicological side effects. Biomaterials 2004;25:5547–56.
Hardes J, von Eiff C, Streitbuerger A, Balke M, Budny T, Henrichs MP, et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol 2010;101:389–95.
Darouiche RO. Antiinfective efficacy of silver-coated medical prostheses. Clin Infect Dis 1999;29:1371–7; quiz 1378.
Collinge CA, Goll G, Seligson D, Easley KJ. Pin tract infections: Silver vs uncoated pins. Orthopedics 1994;17:445–8.
Coester LM, Nepola JV, Allen J, Marsh JL. The effects of silver coated external fixation pins. Iowa Orthop J 2006;26:48–53.
Massè A, Bruno A, Bosetti M, Biasibetti A, Cannas M, Gallinaro P. Prevention of pin track infection in external fixation with silver coated pins: Clinical and microbiological results. J Biomed Mater Res 2000;53:600–4.
Bosetti M, Massè A, Tobin E, Cannas M. Silver coated materials for external fixation devices: In vitro biocompatibility and genotoxicity. Biomaterials 2002;23:887–92.
Lansdown AB. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci 2010;2010:910686.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karakasli, A., Hapa, O., Akdeniz, O. et al. Dermal argyria: Cutaneous manifestation of a megaprosthesis for distal femoral osteosarcoma. IJOO 48, 326–328 (2014). https://doi.org/10.4103/0019-5413.132528
Published:
Issue Date:
DOI: https://doi.org/10.4103/0019-5413.132528